We are live on ! Find out more
BCM

Beddow Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-2.22%
1 Year Est. Return
+18.36%
3 Year Est. Return
+50.71%
5 Year Est. Return
+107.72%
10 Year Est. Return
+272.89%
AUM
$165M
AUM Growth
-$4.73M
Cap. Flow
+$2.43M
Cap. Flow %
1.47%
Top 10 Hldgs %
50.7%
Holding
52
New
3
Increased
30
Reduced
6
Closed
2

Top Sells

Rank Stock Value
1
PHG icon
Philips
PHG
+$564K
2
TPL icon
Texas Pacific Land
TPL
+$400K
3
TKR icon
Timken Company
TKR
+$166K
4
MMM icon
3M
MMM
+$59K
5
OGN icon
Organon & Co
OGN
+$45.3K

Sector Composition

Rank Sector Weight
1 Energy 27.18%
2 Healthcare 19.05%
3 Materials 11.36%
4 Technology 10.11%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1
Texas Pacific Land
TPL
$28.7B
$20.9M 12.66%
105,912
-2,079
-2% -$400K
MSB
2
Mesabi Trust
MSB
$320M
$9.29M 5.62%
431,909
+3,500
+0.8% +$90.2K
ABBV icon
3
AbbVie
ABBV
$450B
$7.16M 4.33%
53,320
+1,875
+4% +$269K
JNJ icon
4
Johnson & Johnson
JNJ
$609B
$6.9M 4.18%
42,243
+125
+0.3% +$21.2K
FNV icon
5
Franco-Nevada
FNV
$38.7B
$6.48M 3.92%
54,237
+300
+0.6% +$37.7K
IBM icon
6
IBM
IBM
$200B
$6.14M 3.72%
51,690
+225
+0.4% +$29.5K
CTRA
7
DELISTED
Coterra Energy
CTRA
$5.98M 3.62%
229,032
+6,745
+3% +$193K
LNG icon
8
Cheniere Energy
LNG
$55B
$5.84M 3.53%
35,185
+1,250
+4% +$190K
BLX icon
9
Bladex Inc
BLX
$2.22B
$5.82M 3.52%
445,611
+400
+0.1% +$5.66K
EOG icon
10
EOG Resources
EOG
$74.5B
$4.87M 2.95%
43,610
+975
+2% +$109K
ALV icon
11
Autoliv
ALV
$9B
$4.48M 2.71%
67,238
+425
+0.6% +$32.9K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.06T
$4.39M 2.66%
16,445
+375
+2% +$107K
BMY icon
13
Bristol-Myers Squibb
BMY
$124B
$4.12M 2.5%
58,010
+500
+0.9% +$36.3K
MRK icon
14
Merck
MRK
$315B
$3.7M 2.24%
42,928
BRK.A icon
15
Berkshire Hathaway Class A
BRK.A
$1.06T
$3.66M 2.21%
9
VTRS icon
16
Viatris
VTRS
$20.1B
$3.64M 2.2%
426,755
+18,729
+5% +$184K
INTC icon
17
Intel
INTC
$478B
$3.56M 2.15%
138,070
+12,660
+10% +$432K
PFE icon
18
Pfizer
PFE
$143B
$3.43M 2.08%
78,423
+550
+0.7% +$26.7K
ORCL icon
19
Oracle
ORCL
$364B
$3.38M 2.04%
55,285
+700
+1% +$51.2K
SI
20
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$3.24M 1.96%
66,271
+1,938
+3% +$94.9K
ABB
21
DELISTED
ABB Ltd
ABB
$3.17M 1.92%
123,512
+350
+0.3% +$9.83K
SHEL icon
22
Shell
SHEL
$242B
$3.13M 1.89%
62,890
+1,200
+2% +$61.8K
KMI icon
23
Kinder Morgan
KMI
$71.9B
$2.99M 1.81%
179,735
+1,325
+0.7% +$23.6K
WPM icon
24
Wheaton Precious Metals
WPM
$47.3B
$2.73M 1.65%
84,198
+4,475
+6% +$147K
OGN icon
25
Organon & Co
OGN
$3.55B
$2.1M 1.27%
89,875
-1,500
-2% -$45.3K

Similar funds

Beddow Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Beddow Capital Management held 52 positions worth $165M, down 2.8% from $170M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Beddow Capital Management's Q3 2022 filing shows 3 new, 30 increased, 6 reduced and 2 closed positions. Its largest new stake was Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities: 20,050 shares worth $560K. The largest sale was Philips, an estimated $564K.

By sector, the portfolio is most concentrated in Energy at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Materials.

  • Beddow Capital Management's largest Q3 2022 buy was Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities: 20,050 shares worth $560K.
  • Beddow Capital Management added most to Intel in Q3 2022, an estimated $432K increase.
  • Beddow Capital Management's biggest Q3 2022 reduction was Texas Pacific Land, cutting an estimated $400K.
  • Beddow Capital Management fully exited Philips in Q3 2022, selling an estimated $564K.
  • Beddow Capital Management's ten largest holdings make up 51% of its $165M portfolio in Q3 2022.
  • Beddow Capital Management opened 3 new positions and closed 2 in Q3 2022.
  • Beddow Capital Management's portfolio value fell 2.8% quarter-over-quarter to $165M.

Based on Beddow Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.